The first monoclonal antibody for cancer

    The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.

    It will be marketed by Roche in Canada.

    Rituxan is for certain cases of non-Hodgkin's lymphoma...a malignancy of the antibody-producing B-cells.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote